Journal article
The dawn of a new era, adjuvant EGFR inhibition in resected non-small cell lung cancer
Abstract
BACKGROUND: Adjuvant platinum-based chemotherapy is standard of care for patients with resected stage IIA/B or IIIA NSCLC. Overall survival is suboptimal due to the high metastatic potential of early-stage NSCLC and there is substantial clinical need for additional efficacious adjuvant treatment options.
METHODS: PubMed (all time to 4 February 2021) and related conference databases were searched using the key search terms 'NSCLC' AND 'Adjuvant' …
Authors
Melosky B; Cheema P; Juergens RA; Leighl NB; Liu G; Wheatley-Price P; Sacher A; Snow S; Tsao M-S; McLeod D
Journal
Therapeutic Advances in Medical Oncology, Vol. 13, ,
Publisher
SAGE Publications
Publication Date
1 2021
DOI
10.1177/17588359211056306
ISSN
1758-8340